CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Vitamin C, Antibiotics, and Caffeine and Others segments. It offers NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Xuanning for hypertension; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; Ailineng for nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; Nuolining for chronic myelocytic and acute lymphoblastic leukemia; and Keaili for breast cancer. The company also provides generic drugs, including Ouyi for anti-inflammatory, Gubang to treat osteoporosis, and Weihong for various infections, as well as Guoweikang, a vitamin C supplement tablets; traditional Chinese medicine; and antibiotics comprising Amoxicillin and Ampicillin capsules, Ceftriaxone and Cefazolin sodium injections, and Meropenum injections. In addition, the company offers antibiotics, vitamin C, and caffeine APIs; and researches and develops various products with focus on the therapeutic areas of cardio-cerebrovascular diseases, metabolic diseases, oncology, psychiatry, and neurology, as well as anti-infection. Further, it provides storage, sourcing, and distribution services; medical services; and sewage products. Additionally, the company engages in the property holding; and sale of pharmaceutical equipment. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. The company was founded in 1997 and is headquartered in Shijiazhuang, the People's Republic of China. Show More...
-
Website http://www.cspc.com.hk
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 0.87 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CNY 0.42 0.07 0.42 0.13 0.17 0.23 0.31 0.38 0.49 0.6 0.6 Dividends CNY 0.21 0.2 0.08 0.06 0.08 0.09 0.11 0.12 0.16 0.16 Payout Ratio % * 42.6 63.1 17.8 46.0 40.1 34.2 29.8 27.8 27.6 26.5 Shares Mil 1.535 4.316 4.583 5.879 5.968 5.958 6.003 6.092 6.242 6.227 6.227 Book Value Per Share * EUR 0.34 0.38 0.21 0.12 0.13 0.16 0.17 0.2 0.28 0.34 0.37 Free Cash Flow Per Share * EUR 0.04 -0.04 0.02 0.010 0.010 0.010 0.03 0.04 0.04 0.02 Return on Assets % 7.92 2.2 17.5 7.39 10.39 13.07 15.32 14.83 15.59 15.01 15.01 Financial Leverage (Average) 1.69 1.86 2.08 1.64 1.55 1.55 1.46 1.4 1.54 1.43 1.43 Return on Equity % 13.58 3.9 34.55 13.66 16.51 20.24 22.99 21.19 23.07 22.18 22.18 Return on Invested Capital % 11.27 3.74 26.3 11.47 14.66 17.92 20.54 19.69 22.78 22.17 22.17 Interest Coverage 16.12 5.29 39.29 18.2 30.83 38.49 64.18 131.12 52.41 143.67 143.67 Current Ratio 1.79 1.41 1.09 1.66 1.83 2.19 2.06 2.37 1.9 2.2 2.2 Quick Ratio 1.31 0.97 0.69 1.1 1.24 1.59 1.52 1.57 1.1 1.37 1.37 Debt/Equity 0.21 0.19 0.08 0.09 0.07 0.12 0.02